First Trimester of Pregnancy: Impact of a History of Miscarriage on Women's Stress

NCT ID: NCT04841486

Last Updated: 2021-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

93 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-11

Study Completion Date

2021-11-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Miscarriage is the spontaneous termination of pregnancy before 22 weeks of amenorrhea. The most frequent complication of pregnancy, it represents 10 to 25% of pregnancies and affects one in four women.

Miscarriage is considered by medical personnel to be common and trivial. however, for women, it is very often a traumatic event, a source of worry for futures pregnancies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to evaluate association between history of spontaneous termination of pregnancy and women's stress during the first trimester of pregnancy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

pregnancy women's stress history of spontaneous termination of pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

"with history of spontaneous termination of pregnancy" group

pregnant women in the first trimester of pregnancy with history of spontaneous termination of pregnancy

Data collection

Intervention Type OTHER

evaluation of women's stress

"without history of spontaneous termination of pregnancy" group

pregnant women in the first trimester of pregnancy without history of spontaneous termination of pregnancy

Data collection

Intervention Type OTHER

evaluation of women's stress

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Data collection

evaluation of women's stress

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* female
* pregnant (positive plasma HCG)
* in the first trimester of pregnancy
* aged 18 years old and more
* agreeing to participate in the study

Exclusion Criteria

\- less than 18 years old
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université de Reims Champagne-Ardenne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sandra CARRAU-TRUILLET, MD

Role: PRINCIPAL_INVESTIGATOR

Université de Reims Champagne-Ardenne - CHU de Reims

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Université de Reims Champagne-Ardenne

Reims, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-001-Stress-FC

Identifier Type: -

Identifier Source: org_study_id